Bishal Gyawali: Inferior Control Arms in Prostate Cancer Trials – The ARANOTE Trial
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, posted on X about recent paper by him as co-author, titled “Inferior Control Arms in Prostate Cancer Trials: The ARANOTE Trial” published on Journal of Clinical Oncology.
Authors: Abhenil Mittal, Geordie Linford, and Bishal Gyawali.
“Please do read our letter to editor to Journal of Clinical Oncology with regards to the recent publication of the ARANOTE trial. Until when shall we put up with inferior control arms?
Congratulations Abhenil Mittal for raising awareness re this important issue.”
Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023